DE69118850T2 - Derivate der 1,4-Benzothiazin-2-essigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung - Google Patents

Derivate der 1,4-Benzothiazin-2-essigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung

Info

Publication number
DE69118850T2
DE69118850T2 DE69118850T DE69118850T DE69118850T2 DE 69118850 T2 DE69118850 T2 DE 69118850T2 DE 69118850 T DE69118850 T DE 69118850T DE 69118850 T DE69118850 T DE 69118850T DE 69118850 T2 DE69118850 T2 DE 69118850T2
Authority
DE
Germany
Prior art keywords
benzothiazine
derivatives
preparation
acetic acid
acetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69118850T
Other languages
English (en)
Other versions
DE69118850D1 (de
Inventor
Tomoji Aotsuka
Hiroshi Hosono
Toshio Kurihara
Yoshiyuki Nakamura
Tetsuo Matsui
Fujio Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Green Cross Corp Japan filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69118850D1 publication Critical patent/DE69118850D1/de
Publication of DE69118850T2 publication Critical patent/DE69118850T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69118850T 1990-12-27 1991-12-27 Derivate der 1,4-Benzothiazin-2-essigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung Expired - Fee Related DE69118850T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP41531690 1990-12-27
JP21934691 1991-08-06

Publications (2)

Publication Number Publication Date
DE69118850D1 DE69118850D1 (de) 1996-05-23
DE69118850T2 true DE69118850T2 (de) 1997-01-09

Family

ID=26523070

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69118850T Expired - Fee Related DE69118850T2 (de) 1990-12-27 1991-12-27 Derivate der 1,4-Benzothiazin-2-essigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung

Country Status (10)

Country Link
US (1) US5252571A (de)
EP (1) EP0492667B1 (de)
JP (1) JP2729430B2 (de)
KR (1) KR0156581B1 (de)
AU (1) AU634109B2 (de)
CA (1) CA2058398C (de)
DE (1) DE69118850T2 (de)
DK (1) DK0492667T3 (de)
ES (1) ES2085950T3 (de)
IE (1) IE914455A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122370A1 (en) * 1992-08-31 1994-03-17 Yoichi Kawashima 3-oxo-1,4-benzothiazine derivatives
JPH06279453A (ja) * 1993-03-29 1994-10-04 Green Cross Corp:The ピリドチアジン酢酸誘導体，その製法及びその用途
US5556841A (en) * 1994-02-04 1996-09-17 Santen Pharmaceutical Co., Ltd. Thiazine or thiomorpholine derivatives
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
JP2003119142A (ja) * 1997-03-31 2003-04-23 Mitsubishi Pharma Corp 糖化蛋白変性物質生成阻害剤
AU5246400A (en) * 1999-06-14 2001-01-02 Mitsubishi Pharma Corporation Process for the preparation of (-)-1,4-benzothiazine-2-acetic acid derivatives
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
MX2013012588A (es) * 2011-04-29 2014-05-20 Icahn School Med Mount Sinai Inhibidores de cinasa.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1453465A (fr) * 1965-08-11 1966-06-03 Kuhlmann Ets Nouveaux antiozones
US3503965A (en) * 1967-12-01 1970-03-31 American Home Prod Derivatives of 1,4-benzothiazine
US3910904A (en) * 1974-08-12 1975-10-07 Monsanto Co 2-Substituted methylene-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-4-acetic acid and esters thereof
IE58312B1 (en) * 1984-05-18 1993-09-08 Union Pharma Scient Appl Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use

Also Published As

Publication number Publication date
IE914455A1 (en) 1992-07-01
CA2058398C (en) 2000-02-15
EP0492667B1 (de) 1996-04-17
JPH0592961A (ja) 1993-04-16
EP0492667A1 (de) 1992-07-01
KR0156581B1 (en) 1998-11-16
ES2085950T3 (es) 1996-06-16
DK0492667T3 (da) 1996-07-08
AU634109B2 (en) 1993-02-11
CA2058398A1 (en) 1992-06-28
JP2729430B2 (ja) 1998-03-18
AU9004591A (en) 1992-07-09
KR920012056A (ko) 1992-07-25
DE69118850D1 (de) 1996-05-23
US5252571A (en) 1993-10-12

Similar Documents

Publication Publication Date Title
DE69210067D1 (de) Hydraxamsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
PT68474A (de) Neue derivate von 3,4,5-trihydroxypiperidin verfahren zu ihrer herstellung und ihre verwendung
DE59108636D1 (de) Neue 5-Chlorchinolin-8-oxyalkancarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antidots von Herbiziden
PT75792A (de) Derivate der cis endo-2-azabicyclo-<3,3,0>-octan-3-carbonsaeure verfahren zu ihrer herstellung diese enthaltende mittel und deren verwendung
DE69225631T2 (de) Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung
DE69211076T3 (de) Polyasparaginsäure-zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung
DE69131807T2 (de) Propensäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
PT78757A (de) Tetrahydropyridazinonderivate verfahren zu ihrer herstellung und ihre verwendung
PT74481B (de) Substituierte n-(4-indolyl-piperidino-alkyl)-benzimidazolone verfahren zu ihrer herstellung und ihre verwendung als pharma- zeutika
PT84460A (de) 1,1-disubstituierte cyclopropanderivate verfahren zu ihrer herstellung und ihre verwendung
PT86380A (de) 2,3-disubstituierte isoxazolidine verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung
PT85302A (de) 7-acyloxy-6-aminoacyloxypolyxylabdane verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69108356T2 (de) Hydrazonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE69118850D1 (de) Derivate der 1,4-Benzothiazin-2-essigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung
DE68920063T2 (de) Derivate von Benzoesäure und Verfahren zu deren Herstellung.
DE69102415D1 (de) Ester der 10-(1-Hydroxy-äthyl)-11-oxo-1-Azatricyclo[7.2.0.0(3,8)]undec-2-ene-2-Carbonsäure und deren Derivate und Verfahren zu ihrer Herstellung.
DE59108499D1 (de) Oligomerengemische von Triphendioxazinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE59108884D1 (de) Triphendioxazinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE68923442T2 (de) N-substituierte Acylaminosäure-Verbindungen, Verfahren zu deren Herstellung und deren Verwendung.
DE59408975D1 (de) Derivate des 3-Fluorphenols, Verfahren zu ihrer Herstellung und ihre Verwendung
DE59206026D1 (de) In 4-Stellung substituierte Derivate von 2,2-Dihalogenbenzo(1,3)dioxolen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69107143T2 (de) 2,2,3-Trimethylcyclopentenylaceton-Derivate, ihre organoleptische Verwendung und Verfahren zu ihrer Herstellung.
PT84618A (de) Bis-tertiaerbutylamino-substituierte 1,3,5-triazinderivate verfahren zu ihrer herstellung diese verbindungen enthaltende arzneimittel und ihre verwendung
DE69127797D1 (de) Acylaminopyridincarboxamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
PT85598A (de) Urdamycin g und dessen derivate verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD., OSAKA,

8327 Change in the person/name/address of the patent owner

Owner name: WELFIDE CORP., OSAKA, JP SENJU PHARMACEUTICAL CO.,

8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PHARMA CORP., OSAKA, JP

Owner name: SENJU PHARMACEUTICAL CO., LTD., OSAKA, JP

8327 Change in the person/name/address of the patent owner

Owner name: SENJU PHARMACEUTICAL CO., LTD., OSAKA, JP

8339 Ceased/non-payment of the annual fee